Targeting mitochondrial metabolism for early detection and treatment of doxorubicin-induced cardiotoxicity (KT) AND Targeting bacterial DNA repair to combat antibiotic resistance (TLH)


E-mail carolyn.thackrah@pharm.ox.ac.uk for joining instructions
Abstract not yet added